<SEC-DOCUMENT>0001564590-22-023137.txt : 20220614
<SEC-HEADER>0001564590-22-023137.hdr.sgml : 20220614
<ACCEPTANCE-DATETIME>20220614084015
ACCESSION NUMBER:		0001564590-22-023137
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220614
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220614
DATE AS OF CHANGE:		20220614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HERON THERAPEUTICS, INC. /DE/
		CENTRAL INDEX KEY:			0000818033
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				942875566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33221
		FILM NUMBER:		221013510

	BUSINESS ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582514400

	MAIL ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AP PHARMA INC /DE/
		DATE OF NAME CHANGE:	20010511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED POLYMER SYSTEMS INC /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hrtx-8k_20220614.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-06-13T17:35:28.9904085+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : c759e47756c54ad4bf1330f94b87543b -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:hrtx="http://www.herontx.com/20220614" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
hrtx-8k_20220614.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0000818033_20220614_20220614">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0000818033_20220614_20220614">0000818033</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="hrtx-20220614.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0000818033_20220614_20220614">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000818033</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-06-14</xbrli:startDate>
					<xbrli:endDate>2022-06-14</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Double 2.25pt #000000;padding-bottom:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0000818033_20220614_20220614">8-K</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of the Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0000818033_20220614_20220614" format="ixt:datemonthdayyearen">June 14, 2022</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0000818033_20220614_20220614">Heron Therapeutics, Inc.</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:30.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0000818033_20220614_20220614" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:37.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0000818033_20220614_20220614">001-33221</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:29.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0000818033_20220614_20220614">94-2875566</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:30.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:37.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:29.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:56.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0000818033_20220614_20220614">4242 Campus Point Court</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine2" contextRef="C_0000818033_20220614_20220614">Suite 200</ix:nonNumeric>, <ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0000818033_20220614_20220614">San Diego</ix:nonNumeric>, <ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0000818033_20220614_20220614">CA</ix:nonNumeric></p></td>
<td valign="bottom" style="width:0.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0000818033_20220614_20220614">92121</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:56.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices)</p></td>
<td valign="bottom" style="width:0.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code <ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0000818033_20220614_20220614">(858)</ix:nonNumeric> <ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0000818033_20220614_20220614">251-4400</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">N/A </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:WrittenCommunications" contextRef="C_0000818033_20220614_20220614" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:SolicitingMaterial" contextRef="C_0000818033_20220614_20220614" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementTenderOffer" contextRef="C_0000818033_20220614_20220614" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0000818033_20220614_20220614" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:39.92%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:22.6%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol(s)</p></td>
<td valign="bottom" style="width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:34.84%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:39.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0000818033_20220614_20220614">Common Stock, par value $0.01 per share</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:22.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:TradingSymbol" contextRef="C_0000818033_20220614_20220614">HRTX</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:34.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">The <ix:nonNumeric id="F_000022" name="dei:SecurityExchangeName" contextRef="C_0000818033_20220614_20220614" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;&#160;<span style="font-family:Segoe UI Emoji;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0000818033_20220614_20220614" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Segoe UI Emoji;">&#9744;</span> </p>
<p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Double 2.25pt #000000;padding-bottom:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 7.01 Regulation FD Disclosure.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;" id="part_1_2_2">On June 14, 2022, Heron Therapeutics, Inc. issued a press release announcing that <span style="color:#000000;">the results from a new study evaluating the efficacy and safety of ZYNRELEF<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> (bupivacaine and meloxicam) extended-release solution as the foundation of a perioperative non-opioid multimodal analgesic regimen in patients undergoing total knee arthroplasty have been published online by the </span><span style="font-style:italic;color:#000000;">Journal of Knee Surgery</span><span style="color:#000000;"> in an article entitled &#8220;HTX-011 in Combination with Multimodal Analgesic Regimen Minimized Severe Pain and Opioid Use after Total Knee Arthroplasty in an Open-Label Study,&#8221; </span>as described in the press release furnished herewith as Exhibit 99.1.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.01 Financial Statements and Exhibits. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Exhibits. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit No.</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="bottom" style="width:89%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:89%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:10%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:89%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="hrtx-ex991_6.htm"><span style="text-decoration:underline;">Press Release, dated June 14, 2022</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:10%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:89%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics, Inc.</p></td>
</tr>
<tr style="height:12pt;">
<td valign="middle" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td style="border:none;padding:0;"></td>
<td style="border:none;padding:0;"></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="width:49%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: <span style="color:#000000;">June 14, 2022</span></p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:49%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/  David Szekeres</p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Szekeres</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Executive Vice President, Chief Operating Officer</p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>hrtx-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
hrtx-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gqv4flczpwou000001.jpg" title="" alt="" style="width:152px;height:59px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;letter-spacing:-0.1pt;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk31720604"></a><a name="_Hlk480203125"></a>Heron Therapeutics Announces Publication Showing ZYNRELEF<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> as the Foundation of a Perioperative Non-Opioid Multimodal Analgesic Regimen Reduced Severe Pain and Opioid Use in Patients Undergoing Total Knee Arthroplasty</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SAN DIEGO, June 14, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced the online publication of a new study evaluating the efficacy and safety of ZYNRELEF (bupivacaine and meloxicam) extended-release solution as the foundation of a perioperative non-opioid multimodal analgesic (MMA) regimen in patients undergoing total knee arthroplasty (TKA). ZYNRELEF is approved by the U.S. Food and Drug Administration (FDA) for use in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.</p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The study was published in the <font style="font-style:italic;">Journal of Knee Surgery, a</font> peer-reviewed journal. All patients in the study received ZYNRELEF with an MMA regimen consisting of a nonsteroidal anti-inflammatory drug (NSAID), acetaminophen and a gabapentinoid. The study showed that more than 80% of patients did not experience severe pain at any individual time point through 72 hours after TKA surgery. Forty-seven percent of patients took &#8804;20 morphine milligram equivalents (&#8804;4 oxycodone 10mg tablets) over the 72-hour postoperative period, 12% of patients remaining opioid-free through 72 hours. Additionally, 39% percent of patients were discharged without an opioid prescription and did not call back to the study site to request additional pain medication between discharge at 72 hours and the Day 11 follow-up visit. Patient satisfaction with pain management was very good with 88% of patients reported &#8220;good&#8221; or &#8220;excellent&#8221; pain control 24 hours following surgery, with all patients maintaining that same level of pain control at 72 hours. Approximately 61% of patients were ready for discharge by 12 hours after surgery and up to 69% by 24 hours. </p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The use of ZYNRELEF 400mg/12mg in patients undergoing TKA with bupivacaine spinal anesthesia and scheduled MMA did not identify safety concerns, and there was no evidence of NSAID-related toxicity, suggesting that the MMA regimen did not impact the safety profile of ZYNRELEF.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Total knee arthroplasty procedures have typically been associated with significant postoperative pain and high opioid requirements. The results presented in this study are promising for ZYNRELEF&#8217;s ability to reduce severe pain and opioid consumption,&#8221; said Gwo-Chin Lee, M.D., Orthopedic Surgeon at Hospital for Special Surgery. &#8220;While controlled clinical trials are needed, I am encouraged by the results in this group of patients showing ZYNRELEF&#8217;s effectiveness when paired with a scheduled non-opioid multimodal pain regimen.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Postoperative pain is one of the main concerns we hear in the clinical setting, and as many orthopedic procedures continue to transition to the outpatient setting, it is becoming increasingly more important to manage pain effectively so patients can be ready for discharge the same day,&#8221; said Alan Rechter, M.D., Orthopaedic Surgeon at Orthopaedic Associates LLP. &#8220;These data reinforce ZYNRELEF&#8217;s ability to provide long-lasting pain control in the critical</p>
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gqv4flczpwou000001.jpg" title="" alt="" style="width:152px;height:59px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">postoperative period, and it is exciting to see its potential to bring positive change to the overall patient experience as the foundation of a multimodal analgesic regimen.&#8221;</p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In this single-arm study, patients undergoing unilateral TKA under spinal anesthesia received ZYNRELEF 400mg/12 mg instilled without a needle into the surgical space in conjunction with a non-opioid MMA regimen consisting of preoperative oral acetaminophen, celecoxib and pregabalin, and postoperative oral acetaminophen and celecoxib for 72 hours followed by oral acetaminophen and ibuprofen for 4 days. Patients were required to stay in the treatment facility to collect pain scores through the 72-hour time point following surgery. Rescue medications, including oral immediate-release oxycodone, IV morphine, and/or IV hydromorphone, were permitted on request.</p>
<p style="margin-bottom:8pt;margin-top:0pt;margin-right:2.8%;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ZYNRELEF is the first and only therapy for postoperative pain management to be rigorously tested in Phase 3 studies and demonstrate superiority to bupivacaine solution. ZYNRELEF demonstrated superior, sustained postoperative pain relief for up to 72 hours and decreased the need for opioids, with more patients opioid-free compared to bupivacaine solution.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk3903047"></a><a name="_Hlk479741885"></a>The <font style="font-style:italic;">Journal of Knee Surgery </font>article can be found <font style="text-decoration:underline;">here</font>.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Important Safety Information for Patients</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">ZYNRELEF contains an NSAID (non-steroidal anti-inflammatory drug), a type of medicine which:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">can increase the risk of a heart attack or stroke that can lead to death. This risk increases with higher doses and longer use of an NSAID.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">cannot be used during heart bypass surgery.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">can increase the risk of gastrointestinal bleeding, ulcers, and tears.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:7.76%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ZYNRELEF should also not be used:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-family:Arial;color:#000000;">if you are allergic to any components of ZYNRELEF, similar local anesthetics, aspirin or other NSAIDs (such as ibuprofen or naproxen), or have had an asthma attack, hives, or other allergic reaction after taking any of these medicines. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-family:Arial;color:#000000;">as a paracervical block, during childbirth.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The most common side effects of ZYNRELEF are constipation, vomiting, and headache.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The medicines in ZYNRELEF (a local anesthetic and an NSAID) may affect the nervous and cardiovascular system; may cause liver or kidney problems; may reduce the effects of some blood pressure medicines; should be avoided if you have severe heart failure; may have adverse effects on cartilage; may cause a rare blood disorder, or life-threatening skin or allergic reactions; may harm your unborn baby if received at 20 weeks of pregnancy or later; and may cause low red blood cells (anemia). </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Please see full Prescribing Information, including Boxed Warning.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">About ZYNRELEF<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> for Postoperative Pain</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ZYNRELEF is the first and only dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of nonsteroidal anti-</p>
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gqv4flczpwou000001.jpg" title="" alt="" style="width:152px;height:59px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:8pt;margin-top:0pt;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inflammatory drug meloxicam. ZYNRELEF is the first and only extended-release local anesthetic to demonstrate in Phase 3 studies significantly reduced pain and significantly increased proportion of patients requiring no opioids&#160;through the first 72 hours following surgery compared to bupivacaine solution, the current standard-of-care local anesthetic for postoperative pain control. ZYNRELEF was initially approved by the FDA in&#160;May 2021&#160;for use in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after bunionectomy, open inguinal herniorrhaphy and total knee arthroplasty. In December 2021, the FDA approved an expansion of ZYNRELEF&#8217;s indication. ZYNRELEF is now indicated in the U.S. in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures. Safety and efficacy have not been established in highly vascular surgeries, such as intrathoracic, large multilevel spinal, and head and neck procedures. In&#160;September 2020, the&#160;European Commission&#160;granted a marketing authorization for ZYNRELEF for the treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults.&#160;As of&#160;January 1, 2021, ZYNRELEF is approved in 31 European countries including the countries of the&#160;European Union&#160;and European Economic Area and the&#160;United Kingdom. In March 2022, Health Canada issued a Notice of Compliance for ZYNRELEF for instillation into the surgical wound for postoperative analgesia after bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty surgical procedures.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please see full prescribing information, including Boxed Warning, at&#160;<font style="text-decoration:underline;">www.ZYNRELEF.com</font>.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">About Heron Therapeutics, Inc.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#1E1E1E;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics, Inc.&#160;is<font style="color:#000000;"> a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit </font><font style="text-decoration:underline;color:#000000;">www.herontx.com</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Forward-looking Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially, including, but not limited to, the potential market opportunity for ZYNRELEF in the U.S.; the extent of the impact of the ongoing Coronavirus Disease 2019 pandemic on our business; and other risks and uncertainties identified in the Company's filings with the U.S. Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Investor Relations and Media Contact:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Szekeres</p>
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gqv4flczpwou000001.jpg" title="" alt="" style="width:152px;height:59px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Executive Vice President, Chief Operating Officer</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics, Inc.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dszekeres@herontx.com </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">858-251-4447</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gqv4flczpwou000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gqv4flczpwou000001.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !A /<# 1$  A$! Q$!_\0
M'P !  (" P$! 0$           @)!PH$!08#"P(!_\0 5Q   00" @$ ! 8)
M#P<*!P  ! (#!08!!P ("1$2$Q05%ADA6-87(B,Q-W:6E]4*)#8X5E=9=WB4
ME;.TM=AA<71U@;:W&#(T.3I!0E&QPC6(D=37\/'_Q  = 0$  @(# 0$
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M.ID*H$NWCR8:ES<KTG/&5P]$:%;QM;@Q>1C$X3J18WKL?)LC,[7LV<TO<@I
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M1TV6-.RN2+T$BV3X>07+1,7*.1TC$+DH\(]<3,-,,2T8HP9LA4?*,#$%CLR
M67,C&M,%DLMDMN(;(>0G#BMDU'+%+9(,5+%@<J;$"U<F,%V,@2(88'/:<"11
M!1,04QYZ^@]2Q-JI6M%7L5"LUTOFK; %VZTN6+)KV06QJPL)DO#< -8 L$H%
MAQ$%/8\[->C3C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33
MC33C33C33C33C33C33C36#=HZZNMZL5;98L-3E]1'"%P&VM.WRFQ<]!7&%,7
MEQJ7AYI(V)B*L,8YE*D@GN2=>DFQQ,8#B3&G9$C#Y*A;NO0,.JMQ9B:,IBKM
M5;DVTGYPU3>WQ5O7/^@<L0R!'U5%$F4(W/M[-9O(XT5Y#%6MIN4ZANO:&=P]
M6]2R]-Q=P7*=V%Q<JY"J7G"'E9Q]D5ICP:C@.RRE_P B?C'K\3")VAULH!;,
M*UZJ;WKBG,'&GQ;Z%*6+>Z=')48=Z6U*R/8XJ.2XEI'L9A@+W94ZZBF^HFPK
M5,Z^XMHU9(JJ8JY##K63ENJ_%!@CF3:KMX6](S,@(J<J!%1R&H_7GW->$5C6
MYG8VWWJQK"%F9P>#%YW<=<"9*ON/!JB7N!BRF1R%:N)#$3Z5")4S('%1FP>N
M1E:U%4]P72>MM9GY6ZF:EEJ?:M?3]0DI-EJMEV^O7&!LII#@$H/AF/(8E$.!
M1Y3)HJFFVBPB,NHP&U^FF]LYL_<.:VKMF]DFX"]5R=_;LU"FS1J9&]2Q"SQM
M0IBYGT7+6135BC1J^E4B.7\-!4NUJ9N[IVFG@,%O/=&<S.*MONNV)E4Y# WL
M';R *QMC-8;/U<L]QU8))5"7=<Q*I985X'82+/EYFA;EUT!3G:?I^N5T?;=G
M*CXG8.Y=NU33-J#9'9!>A*Z#1[19("6*IT>RN4-/M-E>, DVW0(5;<@,-$.Y
M7NGO3W./7CHGT]P4[2WEG]RCG]Q5,?D-C[+C=%N<>G(T,KEKA8?$16,,9C:Y
MJMLS%H45F+;84UC5=I3./V]UA7C<!1VEM!]_![KW#4FKEMR[W3MERPBG(8C#
M5J%G(57%C2M,R;;=S(%*[3934,'BI!2S.>Q^BV]([;D=H:(K]PV.F!*B8?,Q
M7*/98>GVJ=>!"(,)38I,0.-:K,*HC(YLP_D2.:PP>5[PT(EDK.A%K:6?Q&Y<
MK1Q6)M9+*9"Y(*S$UK7HE,+$0UT(=:"9,EFV8L77N!?<OO(27!2RPMU=%-ZW
M-QXG8;HS6XZ>$*I5L>]F$R-+&[ES$I0;K%G*6%UZH8BG)2MKR!:1XM-\=:_#
M>.PUH[Q[:_T#K*/-IU:UW-]G HGWH/;EXA3)V,@[B4C"$FPL7ZZ%B0]6;>>;
MKXH#488:H9M\TL0F1-(1?V V'3V]AZRJRZ=K<%=9L#+7E&\%W[$Q+;"US,%V
MJF>%3'8UD+"&,&9F1WMVCT&P.R< %S#XS;MKJ6%433NK,TW7:E#*2'8IE*I$
MC*:.( S''IKA5:V5^(UJ6V7MB>5%A[- 5&!A[E;W[[:@@$-SUO(AHBO9G)-:
MUO$E,P<$,+&182%N>[1X3*'GF06!TG'2)V"9 F<4U6$54*MVINV0"(?:E2D>
M,R9F2*$I$5K")GM (YF @>\V'W&5W8.GDJ&)H5,QESSV40B!OY=E.ICYO62(
MC8T*5%:JU5(R7AUTA!F" 7#WV'^)8;B_KCV;TUVPH!6SM%V<FVTP.R2-3(E"
MH"?KCB)V*"C) X3$?8XV+D%):%F(]S!*1LC.9>RAMU2VG4HF>\-E[BV)E0PN
MYZ04,BRFF^"%VZER)JO8]2F2VFYZHDCKMCLD^^(&)D8@AF<'L??FV.HN&9GM
MI7F9#%JO/QQO;2NT"BW757<U?@7D5W3 KLI*&0OPR[I@2F1*(SYR*ZF.G&FG
M&FG&FL!R79O343V'@.JYUG)9W=9Z4]L*&JF("?=&*J@^9I+LBJQ-1JZZ.XG-
M>EOUD1)M&J]W3ZH^?;L>TE2=E[B?M*WOA5("VU2R0XFS>]+J"87CBM(IBG+H
MN'$^EH^J@B51WSR?JEQ#G[\VQ6WK3Z>NO-'=5_%%FJM"*5TE,QP3:@G3>%$T
M0*)I6/J1V!;/9' >N'=%#9?ETZ%ZBV!<=7WW;TK#W2A6&3JUHBVM:;+DVP)N
M')6(>*B0C*H7'F)9?;6C! 9+X[N,>LTZM.<9Y.L-T"ZI9_%8_-XO 5[&.RE1
M-ZD\LUA4DVM8"&*.4NOK<N2&8F08 F/Q$,3JN\[[I'I#MO,Y/ 9C<=NME,/=
M?C[Z V_G[ IM5F2MRQ?7QS$-@3&8@U,,"^,2F//7A_ENO&]^_A,_FFVQ]3.9
M/Z6OK#[-5OQ_@?TCK$_36=#_ &IN_P V=R?HK3Y;KQO?OX3/YIML?4SCZ6OK
M#[-5OQ_@?TCI]-9T/]J;O\V=R?HK3Y;KQO?OX3/YIML?4SCZ6OK#[-5OQ_@?
MTCI]-9T/]J;O\V=R?HK3Y;KQO?OX3/YIML?4SCZ6OK#[-5OQ_@?TCI]-9T/]
MJ;O\V=R?HK7($\V'CD.+%"&W;,+),(9%'1G5&UD86^0XEII&5KIJ4)PIQ:<>
MLI6$I]/I5G&,9SS@SW-W5]0&P]MUH!8$9S[_ &!G@0B2*>(R,S/$1,\1$S/V
M-<U>ZHZ).8M2]T79-I@L(^AK<D<F90(QS.+B(YF8CF9B(^SK-G8?R4]/.J^P
MU:KW=LN1JMW3!QEB5%"T.]V)K$3,**3'D_"-=KLG'>L\H,C&6/>O;M>IC+K:
M/63Z8WM+HWU!WQB8SFVL,F]C9LNJ0\\KBZ9>/7@):'@W+B'<#X@>MV=I<^K,
M\3J5;UZZ=-.GN:G;VZLY9Q^5BHB[-=6&S-X?1K,LA)^/1HV$<E*CY#Q.\>/6
M&.8YP7\MUXWOW\)G\TVV/J9R3_2U]8?9JM^/\#^D=1+Z:SH?[4W?YL[D_16G
MRW7C>_?PF?S3;8^IG'TM?6'V:K?C_ _I'3Z:SH?[4W?YL[D_16GRW7C>_?PF
M?S3;8^IG'TM?6'V:K?C_  /Z1T^FLZ'^U-W^;.Y/T5I\MUXWOW\)G\TVV/J9
MQ]+7UA]FJWX_P/Z1T^FLZ'^U-W^;.Y/T5K.VB/)ATB[(VP.A:IWM!R5WDU9;
MBJM8H2V4:5F7\84K D%BZ0,").R"VT+=1&PQ1TAEI"W/=L);7E,7W1T9ZE;.
MH,RF=VQ93C4Q$OO4[5#)HKCY<LL^]MJTRJJ)F!EUA:E=TQ'?S,<R[:'7;I5O
MG(JP^WMV5G95\]M?'WZ62Q%BT?G,+J>^M.FJXZ8B2A%5CG=L3/A\1/$[>5AJ
MW=>%V!L_6VJ(-=FVA?Z7KJO-^OA4W=[/"U:+RMM/KJ:;-FS0AW7O1G'JL-+6
M\O*DI0A2E)QG)XK"YC.V8I83%9'+VYXXK8VE9O/XF>(*5UEL,1^/DBB!CB9F
M8B)UB<QGL'MZI-[/YC%X6D//-K*WZN/K\Q',C#;35 1><< ,R4S,1$3,QJ!M
MG\P7CCJ9;H$AV8@9 IGT^GXL4S9MN$7Z,YQ]RE:S2I6(=^?'S90?G&<>A6,^
MK\_+1I>Y^ZOWUBU6S+2@+]VY+"X]D?[2+N218'^57\'QZJ#(>Z6Z(XUI)=OF
ML]@__3\1N#)*G_9L4,38K%_([_RUSZCY<?'3=C&P(GL]4H\EQ2$XS;J[?J&&
MG*U92GVDI=:E 13:?F]*UJ.PAM.<9<4C&>=>0Z!]7<:N6V-E7FA$3/\ B^YB
M<HR>(YGA&-R%M\S^Q$*YF?*(F==V,]T?T4RS836WY02<\1_C.AFL.J.9XCFQ
ME<;3KQ_#/B\1'UTQJ>U1NU-V!"#6:AVVLW:N&?\ 0Y^HST59(4K[5*_UO*PY
M1@+WVBT*S[-]7H2M.?O*QZ:LOXW(XJR=/*4+N-MK_P I5OU7T[(><QZZ+ +8
M/G$QYC'G$_L:N#&Y3&9BJN]B,C1RM)O^2N8ZW7O56>43ZEBLQJB\IB?5.?*8
MG[.O3\\6O?J(^NN]75;:>Z;SUXJ.VHA>Y->V.?J<]1YP":K$B5/5:5/A9^/K
M)%BCHR/M[\6?&F8);K)DJY@5K,@E"@,X)Y/LOTPWQ@]N8S=M_ OC;N6IU+]7
M)UG5KJ@JWD*LU&W0J.<['BY3E]DW5HB6%X//B^IJN,)U;Z?;AW3E]EXW<5>=
MS86]<QUS%6T6\>YES'V'5;B<>R\A",F5=R&]\4&V)\,?'B)3,,U+CD!U8^H^
M]F>OFK>RNK2M?;>8E%52.G(*[I.@B<!S<6?4B_A#+\<5[C(N-8D8O,I7Y1(X
M;AA,%-2H@3@QA#!3$IVAN?,;4RQW<+X!V+^/OX1]>U!S6LU<LB:QK;V/K$))
M=*+E9L/7"+E6L\ID5R)5_P!3.GNU.INU;&V]Y(>[#!;I9<BJ'X5M#L6Z+,&A
MD)>0>,B+%*QX2I<=2U86@E.-;0T8] =3]H[SO\QUYU<][_8ISL9(5U5X:)8C
MP837&NY:U&;#N;CZR DKC6(R=IAS L>O,E(NN !Q3#Q9 [+_ -1-U;]Q&V,0
MC>F<$DIJ[7L/FA(F;G7]PNQIX[%K 09VNLNQ=NJ;3&%UP%IO,$ \A^1.U>DC
M=Y;R7M7"U:]S)*R]&AC,J7FFG1P&(=5S668QK  J]7WPQN7A?<;;3%)KUQ.R
M]"S_ $!*W#)KE>@:\F2EYE,#"Q<,F8L$B1+S\JF+!8!Q)3<L6I94I+G88]ZD
MI$E:R#377B7E*<=5G/R;NV9NW+=R4UZTV[+[,UZ:0K5*\O:;935KKB%HKJ[_
M  T)7$ I0B Q C&OM7CZD8^A2H18M6XI5*U2+=YYVKUJ*R03Z1<M-F66;3NS
MQ+#V3)N<1L.9(IUAC:_:#2VD]C:9U1L>TDPEYW_/%5G5D2S7[!+-6"9#/@8T
M@5^1B8TV.A4H,LL.U@B:* '7@E3B7,MCD*;D6"V3N/<F(W%G</2"SC-J50NY
MQY6ZE<JE=BK3@,$V'+=9F5TK$]E8&G$A$2/)A!1?<6_]K;5S>U]NYN^VKEMY
M7#H;?KA1NV0N6ENIH-;'UD-14B&WJP]]MB0F&24%(@<C('D4U,]:P7@G[H]5
M=+=+K!4-S]AM1ZPMS^][Q-,5R]7F!KDT]"FU77XP<HW'R9@Y*@"203F&"<-^
MR<=$(0E65-+]&X'NDME;PW-U!JY' [9S.7I#MK'5BM8ZA8M(%ZKN4-B98H"&
M& #5D0<\P)C,_'&M0?<T;DVIM#IY:Q6:W!B<3</<V2N#5OW$57RAU+%+!L*:
M<%*S)+!$^.)D"B/BU<]\I;X^OIF=</SL5#])\U_^"GJ5["[H_$]S\UK87X3>
MGOMGMS\:U/SFGREOCZ^F9UP_.Q4/TGQ\%/4KV%W1^)[GYK3X3>GOMGMS\:U/
MSFGREOCZ^F9UP_.Q4/TGQ\%/4KV%W1^)[GYK3X3>GOMGMS\:U/SFGREOCZ^F
M9UP_.Q4/TGQ\%/4KV%W1^)[GYK3X3>GOMGMS\:U/SFJHHO?.H=\>?'1EFTML
MNF[2J;'46QPI-AHM@C[)"L38+>VS3(IT^,?(&1(#"'QY+XRG,.MLF#.*1A+R
M%9NUF#S>W/<S;CQN>Q5[$76;ZJVAJY"NRK8*NR<&L'"IL"4J,TL 3B)B2 XC
MZV>*+B[A]P^Z<VWG<+D:>5J)V):HE:HN"R@7A&=8:9<N2&&"%A9$'/,"8S/U
MT:PMU0V5TRI_D:\K+7;Z=Z_PXC^[ VJ']GEJD.#O$C6_9WQC36,70=]O#S;3
ML+F7S'>JK*%QWO7IQ[#T2'>U3?U_I1T5#8RMS,-.WF>^7T-LR(' '1Q'HGIG
MH!A,CR-CP/%YB)\7L_TM1S8];8-'JOUKL[X#;,KN[B66-^B:MCG!WC?S,V_0
MO?!;(B>#1X\I[9F/"[^8[>+2/L_>%;]W'CR_FFC/T?RFO>+W0'[EZH_A&X_S
MVKH],Z ?M?2W\7[;^;:?9^\*W[N/'E_--&?H_CWB]T!^Y>J/X1N/\]IZ9T _
M:^EOXOVW\VT^S]X5OW<>/+^::,_1_'O%[H#]R]4?PC<?Y[3TSH!^U]+?Q?MO
MYMI]G[PK?NX\>7\TT9^C^/>+W0'[EZH_A&X_SVGIG0#]KZ6_B_;?S;7]M]@O
M"RRXAUJ]^/5IUI:7&W&Q]'(<;<0K"D+0M(&%(6A6,*2I.<*2K&,XSC..?DX#
MK^42)5.J$Q,3$Q+]Q3$Q/E,3$NXF)CRF)^/7Z-WH",P0ATN$AF"$AH;<B1F)
MYB8F*W,3$^<3'G$ZJFO_ &8Z2[$\V,-L.\[6Z_7GKUCK*F%+N%LFJ;9M6XMH
MP<S[I&OG3&3:_F<'>>;]W97G);3CJ<MX3E7IY=.+V[U Q/N>;&&QF)W-C-SS
MO";04J"K]/,>@F=?Q&PNO*[/HYP,]Q1ZA0/GS$:I7+WMA9KW1-?<.6O;;RNV
M8V=%-EK(^@WL/Z:"['AK,[4-J^D 1QV1QWC,QQ,<ZM6^S]X5OW<>/+^::,_1
M_*7]XO= ?N7JC^$;C_/:NGTSH!^U]+?Q?MOYMI]G[PK?NX\>7\TT9^C^/>+W
M0'[EZH_A&X_SVGIG0#]KZ6_B_;?S;3[/WA6_=QX\OYIHS]'\>\7N@/W+U1_"
M-Q_GM/3.@'[7TM_%^V_FVGV?O"M^[CQY?S31GZ/X]XO= ?N7JC^$;C_/:>F=
M /VOI;^+]M_-M4[>6W8?CMV!5=+5OHJC4]G[B2NX:>/KXOJM%1 <FV"XHUG
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MTKZ^#Y>MMNG_ *_+&[DUK#UJH>E=5N@5CB9]#W)</F!YB.<EMLO.?L?6:O\
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M.B;WM0-MQF,TEK&0C[7L(V6RC/NH,V. 0['4<9U?JJ>/N!D5GW;UUQHDJ9[
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M,Y]@A]3]0L)]>(+PX/C#>&3'@%$LHSCUVVW$H7G*L9SS([<SRMQXXLBFNRL
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MW5G$*/)&9CT*93E(ZRDDO?<&7.9I&:SW>17]K-H5%IL.=:]^,=:\.$5VN$?
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hrtx-20220614.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-06-13T17:35:28.9904085+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : c759e47756c54ad4bf1330f94b87543b -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:hrtx="http://www.herontx.com/20220614" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.herontx.com/20220614" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" namespace="http://xbrl.sec.gov/currency/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" namespace="http://xbrl.sec.gov/exch/2022" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" namespace="http://xbrl.sec.gov/sic/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" namespace="http://fasb.org/srt-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" namespace="http://fasb.org/srt-types/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" namespace="http://fasb.org/us-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.herontx.com/20220614/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hrtx-20220614_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hrtx-20220614_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hrtx-20220614_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-06-13T17:35:28.9904085+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : c759e47756c54ad4bf1330f94b87543b -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hrtx-20220614_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-06-13T17:35:28.9904085+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : c759e47756c54ad4bf1330f94b87543b -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.herontx.com/20220614/role/TemplateLink" xlink:href="hrtx-20220614.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hrtx-20220614.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140068765830136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 14,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Heron Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-2875566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4242 Campus Point Court<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">251-4400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HRTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>hrtx-8k_20220614_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hrtx-20220614.xsd" xlink:type="simple"/>
    <context id="C_0000818033_20220614_20220614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
        </entity>
        <period>
            <startDate>2022-06-14</startDate>
            <endDate>2022-06-14</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0000818033_20220614_20220614" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0000818033_20220614_20220614" id="F_000004">0000818033</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0000818033_20220614_20220614" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0000818033_20220614_20220614" id="F_000002">2022-06-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0000818033_20220614_20220614" id="F_000003">Heron Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0000818033_20220614_20220614" id="F_000007">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0000818033_20220614_20220614" id="F_000006">001-33221</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0000818033_20220614_20220614" id="F_000008">94-2875566</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0000818033_20220614_20220614" id="F_000009">4242 Campus Point Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0000818033_20220614_20220614" id="F_000010">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0000818033_20220614_20220614" id="F_000011">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0000818033_20220614_20220614" id="F_000012">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0000818033_20220614_20220614" id="F_000013">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0000818033_20220614_20220614" id="F_000014">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0000818033_20220614_20220614" id="F_000015">251-4400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0000818033_20220614_20220614" id="F_000016">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0000818033_20220614_20220614" id="F_000017">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0000818033_20220614_20220614" id="F_000018">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0000818033_20220614_20220614" id="F_000019">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0000818033_20220614_20220614" id="F_000020">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0000818033_20220614_20220614" id="F_000021">HRTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0000818033_20220614_20220614" id="F_000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0000818033_20220614_20220614" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    (  =%SE1ED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  '1<Y4)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    "  '1<Y499!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hrtx-8k_20220614.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="hrtx-8k_20220614.htm">hrtx-8k_20220614.htm</File>
    <File>hrtx-20220614.xsd</File>
    <File>hrtx-20220614_lab.xml</File>
    <File>hrtx-20220614_pre.xml</File>
    <File>hrtx-ex991_6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hrtx-8k_20220614.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "hrtx-8k_20220614.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hrtx-20220614_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hrtx-20220614_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hrtx-20220614.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hrtx",
   "nsuri": "http://www.herontx.com/20220614",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "hrtx-8k_20220614.htm",
      "contextRef": "C_0000818033_20220614_20220614",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "hrtx-8k_20220614.htm",
      "contextRef": "C_0000818033_20220614_20220614",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.herontx.com/20220614/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-22-023137-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-023137-xbrl.zip
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M(E0#W'/(V,&4P(O:"O+:Y\N??_KTBV6!Z]O^/;AR/?0"KQ%W,>4+!M\-OIR
M;[\_W8$[1'Z,' [!-747,T@\8(%GSYMW;?OU];4^GB#"*5YX@IW773JS@65%
MT#T&'?D+<.UX$/A?7=!JM%I6XX/5; ^;Y]WV6;?UL=[I-$X;'\]^:S2ZC48,
MX*_@M$#LJPO.ZHUZLWY^>AX;^.BX/YPI!/WKV$#W_*P#3\_/SSZX9Z?.^'0T
M:;;;C4GG=/3Q_.RT/8I72N<KAJ;/'GCGGO@EBO,E!&(,5^ 6$8>XR,%@$)WI
M>] G;AU<80R>Y#0.GB"'[ 6.ZR$J%KIU<22>\(AP_\>+6DR]Y8CA.F53N]5H
MM.UH="T<OMP9_]KV1S<[G8[M_W8]E"/50 ';M+]]N1NXSW#F6,(JD0)7$G#4
MY?[!.^KZ'N6H"Z2.D#]9T3!+'K*:+:O=K"_YN";4 "#0@U$,G^ $R.]?G_JI
MG!U;CK )G(K@C.^<$<2B9A_BF<&)>AYF+#%-UM&1=30_R#I^5:%YJ[GH!XYF
M<RQ4L2N7>@\]O=5N ^HN^!$R1,<W1+/(:MC#%#_P'*99]31@W2<P%-<WJ+?T
M74CM15//P9J+WH'46'2);'B[=58-PL3A(Y]&+,E3QYD'5%B"VLX2\6LX<1;8
MVRV3B\E^C3L(<IFR(?:X/"+AN"4/^04K(--K]JN0"WTX4F)EK =!Y<'J$T.&
M2P^2,0PO^&MLZJ:?$H=N?4I?[#%$P=F(%YMS$#]\OR$>\E8]L>]@#NX+^.6?
M<)7DQ7(%HRPZZ)_,12UCLITL4(Z7RZAX);=,D%A?!WG!ON/15B88Y'3!_#4V
MMY;>IF<O QH0\@"?" BF3_:FH-WZKYB;J,)A;E2 >+FGAG"$[5*Q-YA[%HXG
M?<+H+%/-D);N5<G6F8L>%5O>JQ$7-*Z7-P];D\KE( &BQ_] \$L?&?P;8?]W
M?,O5*M-4(;1:'-UP#,7IY74X.:><P7$,/?X*G49TW>'K&RE)<'R/E3+3-"E,
MD107TK):$*\$PUBRW&)GFC>)6Y/*Z98 T;_6K.&!Q#]^%-5"TU0MC!$5%]-3
MSW5Q?8\EGZX4O4!N3:[6U@DP_3%=-WG  P21_T3I^('-MH+N5<DXV;<OJ[D5
MU['+?X)3)'<3Q+MW9KD3K9Y;98^?Q#K8%G]# R3/\=.<Z0+=IY!IBN/R8A_W
M;C!9>($;01T]>#.#;(K(] ]&7[WG'IW-'5+P?CL%HDH^E) ':\R(#01T(.0S
MI4&S+:(Y=3/4#ES-"1TM<(LPO%_,1I 5RWU\7A5U-S@'2[BD  &'*:E6J$ZS
M5#%)85Q<7!U![1.7LCEE_M_O!I[8G_7H0JP6JQX=%]P^[8&J(G8F],$2GF!]
M#WQ>0!D(N8$D-R7Z^7RD!44UW#.<;E?H5CZK=#32T%GVQV*?A28H^&-XF<M_
M*D@5(U) #]8V@@\D"0U;)O9917.K9ZPMN*HC.EKB:CP6M?/PVQTBL%FL'90
M5317 !ZL#4*2]]$+^2XH"!Z(,4M&ECTTEVI&6H%5+B1,:+YU[%M58]_2K77K
MC6,_?*7FQKZ5-_:M0\1>DQ7[8]]ZD]CWQ,L'-J2OI%3HX],UZ+R!.WS@)9>\
M/9!LAH5=88HJZMMJ&6B .N:^] _[I->8<O_NXH$],OJ"B%OP1CD-0X/<6YB'
M#_WZICBB-"SY:4:IXJ\4SU13U(T0V/&0QPZ-W?!(N>?@?]"\^$,C-8(&T1.(
MA^^#@ X(/J,>"V4:I.H!A6QFFJ'.?VX;*KYS4)X:@TZ1O"?GE'S?8 Q#?Z;]
M553"&Q)AI<HT30E3%,7%Q*P61/G)&_SX3$G!OS;MSBLGWS:._E#Z#,"G,.8Q
M8JKJ-$L5DQ3&Q<6M%M2_&?(\2'IT-EN0\"$DSYO6E,GE!%6"Z<]M2 .2/,?/
M;K81=*]&QHF.R^E=+<X#BI&+/$2F7\2&FR$'Y\VR:F8Y37>1]*=XPP$BDN-'
M.$-\FBV-64+C$AI7B^TC@[(_H)#7?RN]_*P5>YA,\F\<LA#*J9N.J#_.@LMR
M8V0@8 ,^W?&#G<,>FD\T,ZW :Q= K[@+6J/?YWP!6?4&4.!HT7X']PV:(> T
MNR?2?5-W1HJ.)GN4UB6%[*FXO8'N0NRG5LW6:(@\G/L9Q^Z\DBON%H[^\/NP
M@$Y L_5N= (BPN/G/55ZFB6-23)'VYH-./#1#Q76(7/D/ZH9K&8CFGL;OC6I
MG'X)D -D-( ' ?[QHZD6FJ9J88RHN)B>>JZ=-TOW69PH+/(Y)/7<:LT=QSK
M#6+( B(:0SZ'E.D"W:>0:8KC0F+'#]R)5_)?286'4/#OE2[_!U!+ P04
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M_]+9)>"^%B$_J .8#\F3[$FQH)NES^5@CV+D!U>/X),<BB7_)J3[[OF!W'[
M&H.4O@GF88#O M1]*U W%Z!#;]7Q86J@XZVZ7:9!KP3) 3#4/4+.A(S:B6Z,
MMICS4*XOEX)70N4 _IZR"T7^V"\'6'<!D1.8@3])L0RG,-G-/+Z^#.&)$#F
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M\J\O4W[S/=Y>B[ Y*"5 ]P",D$A[A]0 FX&ZY!$91VXO>0U&0$8)D@PA.EH
MH.93U0 [O)U65-2.[:_(W&U,T%UO\6\O\5_6#B69-=659>9]R\[&:*7*-04,
M("@'+GQG0[2RGOVI R'!D1 G#-NI ';X4DH[UH%^G:^CU1Y.1\+8O*_R5@@N
MVP[:U5DE^,X+X3(T\J7$44<@WH:%O]1C%CD\3DDD^!=>!)>%<_U]G^!NFB";
MWJ07?)#NW=8KWM0(^Q WX1>]N4W&W_86"RLAU.:X(&;Y=W)>VUL'L^ X^S"1
M46.N(_*J$9FQA;:1(=>G3MVT4T&MU-5:,J$'=\-&E6IE4A!/PO])JYC)2I/1
M&=V%-#0I\28-!<?]GTWVBNG8Q^QP+9G'"%?H!C_%TP-Q,^V<7UP(*9WK \<-
M:A1^LLW;&_5V'WQQQ6IGXQEE=&E]?MODZ3RL@7@G<$-LV$HM$<!!"/34@(F6
M7@6!?"AXDA#9'[/&:N7S6;'**(N*QDB+&$W+(!I+*8:P?-%:-FB]&3>O4D;
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M)M-XF_).JX%VT0JT]4<$VB"4\^S_Z/-T5+.ZJ9$$VW@#9^ON5LA^58'3VTC
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M4$L! A0#%     @ !T7.5(/$0_<R!P  \DL  !4              ( !X00
M &AR='@M,C R,C V,31?;&%B+GAM;%!+ 0(4 Q0    (  =%SE1+4VV5#P4
M !8M   5              "  48,  !H<G1X+3(P,C(P-C$T7W!R92YX;6Q0
M2P$"% ,4    "  '1<Y47HE3BBD1  #]BP  %               @ &($0
M:')T>"TX:U\R,#(R,#8Q-"YH=&U02P$"% ,4    "  '1<Y42?L5'6D4  "&
M<   $               @ 'C(@  :')T>"UE>#DY,5\V+FAT;5!+!08
..!0 % $4!  !Z-P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
